Omega-3 Fatty Acids in the Treatment of Autism Spectrum Disorder

Abstract

Several open studies and a small number of small clinical trials have been performed with omega-3 fatty acids in autism. These trials were based both on the reported etiological abnormalities of fatty acid metabolism in autism and also on the reported efficacy of omega-3 fatty acids in other syndromes such as obsessive compulsive disorder and depression. This literature is too small to summarize by a meta-analysis. However, in summarizing this data it appears too early to recommend omega-3 fatty acid as standard treatment. However, data suggests that some subgroups of autistic patients and individual patients may benefit significantly from this treatment and that further research and clinical trial are indicated.

Keywords

Autism Spectrum Disorder Obsessive Compulsive Disorder Autistic Disorder Premature Closure Skeptical Attitude 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Amminger GP, Berger GE, Schafer MR, Klier C, Friedrich MH, Feucht M. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry. 2007;61:551–3.PubMedCrossRefGoogle Scholar
  2. Belmaker RH, Bersudsky Y, Agam G. Individual differences and evidence based psychopharmacology. BMC Medicine. 2012;10:110–113.Google Scholar
  3. Belmaker RH, Levine J. Inositol in treatment of psychiatric disorders. In: Mischoulon D, Rosenbaum JF, editors. Alternative medications and the treatment of psychiatric disorders. Baltimore: Lippincott Williams & Wilkins; 2008. p. 105–15.Google Scholar
  4. Bent S, Bertoglio K, Ashwood P, Bostrom A, Hendren RL. A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. J Autism Dev Disord. 2011;41:545–54.PubMedCrossRefGoogle Scholar
  5. Bent S, Bertoglio K, Hendren RL. Omega-3 fatty acids for autistic spectrum disorder: a systematic review. J Autism Dev Disord. 2009;39:1145–54.PubMedCrossRefGoogle Scholar
  6. Einat H, Belmaker RH. The effects of inositol treatment in animal models of psychiatric disorders. J Affect Disord. 2001;62:113–21.PubMedCrossRefGoogle Scholar
  7. Einat H, Clenet F, Shaldubina A, Belmaker RH, Bourin M. The antidepressant activity of inositol in the forced swim test involves 5-HT(2) receptors. Behav Brain Res. 2001;118:77–83.PubMedCrossRefGoogle Scholar
  8. Einat H, Karbovski H, Korik J, Tsalah D, Belmaker RH. Inositol reduces depressive-like behaviors in two different animal models of depression. Psychopharmacology (Berl). 1999;144:158–62.CrossRefGoogle Scholar
  9. Freeman MP. Omega-3 fatty acids and perinatal depression: a review of the literature and recommendations for future research. Prostaglandins Leukot Essent Fatty Acids. 2006;75:291–7.PubMedCrossRefGoogle Scholar
  10. James S, Montgomery P, Williams K. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database Syst Rev: CD007992, 2011.Google Scholar
  11. Johnson C, Handen B, Zimmer M, Sacco K. Polyunsaturated fatty acid supplementation in young children with autism. J Dev Phys Disabil. 2010;22:1–10.CrossRefGoogle Scholar
  12. Johnson SM, Hollander E. Evidence that eicosapentaenoic acid is effective in treating autism. J Clin Psychiatry. 2003;64:848–9.PubMedCrossRefGoogle Scholar
  13. Levine J, Aviram A, Holan A, Ring A, Barak Y, Belmaker RH. Inositol treatment of autism. J Neural Transm. 1997;104:307–10.PubMedCrossRefGoogle Scholar
  14. Levine J, Barak Y, Gonzalves M, Szor H, Elizur A, Kofman O, Belmaker RH. Double-blind, controlled trial of inositol treatment of depression. Am J Psychiatry. 1995;152:792–4.PubMedGoogle Scholar
  15. Meiri G, Bichovsky Y, Belmaker RH. Omega 3 fatty acid treatment in autism. J Child Adolesc Psychopharmacol. 2009;19:449–51.PubMedCrossRefGoogle Scholar
  16. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry. 2002;159:477–9.PubMedCrossRefGoogle Scholar
  17. Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry. 2006;163:1098–100.PubMedCrossRefGoogle Scholar
  18. Politi P, Cena H, Comelli M, Marrone G, Allegri C, Emanuele E, Ucelli di Nemi S. Behavioral effects of omega-3 fatty acid supplementation in young adults with severe autism: an open label study. Arch Med Res. 2008;39:682–5.PubMedCrossRefGoogle Scholar
  19. Schuchardt JP, Huss M, Stauss-Grabo M, Hahn A. Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. Eur J Pediatr. 2010;169:149–64.PubMedCrossRefGoogle Scholar
  20. Vancassel S, Durand G, Barthelemy C, Lejeune B, Martineau J, Guilloteau D, Andres C, Chalon S. Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids. 2001;65:1–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Ben Gurion University of the NegevBeershebaIsrael
  2. 2.Department of PsychiatryBen Gurion University of the Negev, Soroka University Medical CenterBeershebaIsrael

Personalised recommendations